Sinovac Biotech annual total assets
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Sinovac Biotech Total Assets Growth & History (SVA)
Sinovac Biotech's total assets was $8.54B for fiscal 2025.
View full Sinovac Biotech company overviewSinovac Biotech annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.54B | −$3.80B | −30.76% |
| 2024 | 2024-12-31 | $12.34B | −$1.27B | −9.36% |
| 2023 | 2023-12-31 | $13.61B | −$418.5M | −2.98% |
| 2022 | 2022-12-31 | $14.03B | −$2.73B | −16.28% |
| 2021 | 2021-12-31 | $16.76B | $14.86B | +781.42% |
| 2020 | 2020-12-31 | $1.90B | $1.45B | +320.37% |
| 2019 | 2019-12-31 | $452.3M | $82.5M | +22.32% |
| 2018 | 2018-12-31 | $369.8M | $70.6M | +23.58% |
| 2017 | 2017-12-31 | $299.2M | $87.9M | +41.57% |
| 2016 | 2016-12-31 | $211.4M | $8.4M | +4.15% |
| 2015 | 2015-12-31 | $202.9M | −$35.6M | −14.93% |
| 2014 | 2014-12-31 | $238.5M | −$2.2M | −0.90% |
| 2013 | 2013-12-31 | $240.7M | $31.9M | +15.29% |
| 2012 | 2012-12-31 | $208.8M | −$7.1M | −3.31% |
| 2011 | 2011-12-31 | $215.9M | $1.6M | +0.72% |
| 2010 | 2010-12-31 | $214.4M | — | — |
Sinovac Biotech quarterly total assets
Q4.10
Q4.11
Q4.12
Q4.13
Q4.14
Q4.15
Q4.16
Q4.17
Q4.18
Q4.19
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $8.54B | −$3.80B | −30.76% |
| Q2 2025 | 2025-06-30 | $11.99B | — | — |
| Q4 2024 | 2024-12-31 | $12.34B | −$1.27B | −9.36% |
| Q4 2023 | 2023-12-31 | $13.61B | −$418.5M | −2.98% |
| Q4 2022 | 2022-12-31 | $14.03B | −$2.73B | −16.28% |
| Q4 2021 | 2021-12-31 | $16.76B | $14.86B | +781.42% |
| Q4 2020 | 2020-12-31 | $1.90B | $1.45B | +320.37% |
| Q4 2019 | 2019-12-31 | $452.3M | $82.5M | +22.32% |
| Q4 2018 | 2018-12-31 | $369.8M | $70.6M | +23.58% |
| Q4 2017 · Dec 31 | 2017-12-31 | $299.2M | $87.9M | +41.57% |
| Q4 2016 | 2016-12-31 | $211.4M | $8.4M | +4.15% |
| Q4 2015 | 2015-12-31 | $202.9M | −$35.6M | −14.93% |
| Q4 2014 | 2014-12-31 | $238.5M | −$2.2M | −0.90% |
| Q4 2013 | 2013-12-31 | $240.7M | $31.9M | +15.29% |
| Q4 2012 | 2012-12-31 | $208.8M | −$7.1M | −3.31% |
| Q4 2011 | 2011-12-31 | $215.9M | $1.6M | +0.72% |
| Q4 2010 | 2010-12-31 | $214.4M | — | — |
Sinovac Biotech total assets trends
Over the last five fiscal years, Sinovac Biotech's total assets increased from $1.90B to $8.54B, a change of $6.64B. The latest reported quarter, Q4 2025, shows $8.54B.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sinovac Biotech source filings ↗